Akers Biosciences Inc. (AKER)

[leifsmith]

"FDA is fully informed of the significance of the MYMD-1 molecule and will likely fast track it."

This would have to be an FDA devoted more to public health than to serving large drug manufacturers. I hope you are right. The MYMD-1 molecule may threaten the sales of many expensive drugs.

To be clear, I am sure there are many people working for the FDA whose objective is genuinely public health.